Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 1, 1998, Pages 33-39

  Xu, Ning ^a   Dahlbäck, Björn ^a   Öhlin, Ann Kristin ^b   Nilsson, Åke ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Department of Laboratory Medicine ^*  (Sweden)

Author keywords

Atherosclerosis; Blood coagulation; Lipoproteins; Triglyceride

Indexed keywords

BINDING PROTEIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CHYLOMICRON; COMPLEMENT COMPONENT C4B; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN G; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; PEROXIDASE; POLYCLONAL ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; SERUM AMYLOID P; THROMBOMODULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VITAMIN K GROUP;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0031964412     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.1.33     Document Type: Article

References (14)

1. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1994;11:2-14.
2. Austin MA. Triglycerides and coronary heart disease epidemiology: statistical and genetic issues. In: Gotto AM Jr, Paoletti R, eds. Atherosclerosis Reviews, 22. New York, NY: Raven Press; 1991:65-69.
3. Lippel K, Tyroler H, Eder H, Gotto A, Vahouny G. Relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis. 1981;1:406-417.
4. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb. 1992;12:1336-1345.
5. Patsch JR. Triglyceride-rich lipoproteins and atherosclerosis. Atherosclerosis. 1994;110(suppl):S23-S26.
6. Steiner G. Triglyceride-rich lipoproteins and atherosclerosis from fast to feast. Ann Med. 1993;25:431-435.
7. Zilversmit DB. Atherogenic nature of triglyceride, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem. 1995;41:153-158.
8. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473-485.
9. Albrink MJ, Man EB. Serum triglycerides in coronary artery disease. Arch Intern Med. 1959;103:4-8.
10. Antonis A, Bershon I. Serum triglyceride levels in South African Europeans and Bantu in ischaemic heart disease. Lancet. 1960;1:998-1002.
11. Goldstein JL, Hazzard WR, Schrott HG, Bierman EJ, Motulsky AG. Hyperlipidemia in coronary heart disease, I: lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 1973;52:1533-1543.
12. Bradley WA, Gianturco SH. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. J Intern Med Suppl. 1994;236:33-39.
13. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lovimer AR, Bonnefous F, Bogaievsky Y, Packard CJ, Shepherd J. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis. 1990;85:193-202.
14. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb. 1991;11:653-662.